Separation systems plays a vital role in commercial biotechnology. Liquid chromatography, membrane filters, flow cytometer instruments, centrifugation systems, and electrophoresis instruments are the major segments of the market. Technological advancement such as automation and high throughput approaches that reduces the cost and time of separation processes dramatically, government support, increasing investment in R&D activities are likely to contribute towards the growth of global separation systems for commercial biotechnology market during the forecast period. These technological innovations support effective and quick separation of molecules, thereby resulting in increased adoption of separation systems in life sciences research, and commercial production of biomolecules.
The global separation systems for commercial biotechnology market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global separation systems for commercial biotechnology market segmentation is based on product types (centrifugation, DNA microarray, electrophoresis, flow cytometry, liquid chromatography, MACS, FACS, membrane filtration, protein microarray), and end users (pharmaceuticals, research and diagnostics).
The global separation systems for commercial biotechnology market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global separation systems for commercial biotechnology market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global separation systems for commercial biotechnology market and included in this report are Affymetrix, Inc., Danaher Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., GE Healthcare, Merck KGaA, PerkinElmer, Inc., Qiagen, Thermo Fisher Scientific, Inc., and Waters Corporation.